Recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer NCT05172245 Conditions Carcinoma, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more Locations Moffitt Cancer Center — Tampa, Florida, United States Northwestern University — Chicago, Illinois, United States University of Kansas Clinical Research Center — Fairway, Kansas, United States University of Kansas Cancer Center — Kansas City, Kansas, United States View all 18 locations View more locations Show fewer locations Loading locations... View Trial Details
